Annual Evidence Update on Age Related Macular Degeneration: 14-18 June 2010

An update of the evidence on this topic from NHS Evidence - eyes and vision.

Age Related Macular Degeneration (AMD) is one of the commonest causes of certifiable visual impairment in the UK. The 2010 Evidence Update focuses on the management of neovascular (wet) AMD and highlights the:

• key evidence base underpinning current interventions (key randomised controlled trials and current guidance);
• new evidence that is likely to inform a change in clinical practice;
• emerging evidence for Lucentis, Avastin and combination treatments from key RCTs that have recently reported at scientific conferences but not yet published in peer reviewed literature;
• current uncertainties in the effectiveness of treatments.

Commentaries have been provided by Robin Hamilton, Consultant Ophthalmic Surgeon and Praveen Patel, Consultant Ophthalmologist, Moorfields Eye Hospital NHS Foundation Trust and by Angela Reidy and Darwin Minassian, EpiVision.

Find out more at www.library.nhs.uk/eyes.

Annual Evidence Update on Age Related Macular Degeneration: 15-19 June 2009

An update of the evidence on this topic from NHS Evidence - eyes and vision.

The Age Related Macular Degeneration Annual Evidence Update (AEU) will be available from 15 June 2009. A collection of the evidence that has emerged since the 2008 AEU will be presented under a number of topics reflecting aspects of the care pathway. The evidence will be categorised into secondary publications (systematic reviews and meta-analyses), interventional studies (randomised control trials and clinical control trials) and observational studies. The emphasis of the AEU will be on the sight threatening or visually impairing forms of age-related macular degeneration.

Find out more at www.library.nhs.uk/eyes.

Annual Evidence Update on Age Related Macular Degeneration (AMD): 16-20 June 2008

The Age Related Macular Degeneration Annual Evidence Update 2008 presents a collection of evidence that has emerged in the past 12 months since the 2007 National Knowledge Week (NKW).

The term Age Related Macular Degeneration (AMD) is used to cover both wet and dry forms of the disease AMD. The dry form of the condition is also known as geographic atrophy and the wet form of the condition is also known as neovascular AMD. The emphasis of this AEU is on the sight threatening or visually impairing forms of AMD.

Searches were limited to the period February 2007 to May 2008 and the findings are presented through a number of topics reflecting the care pathway. The evidence has been categorised into secondary publications, interventional studies and observational studies. Links to the full text articles are provided where available and links to PubMed abstracts in all other cases.

Find out more at http://www.library.nhs.uk/eyes.

NKW for Age Related Macular Degeneration: 18-24 June 2007

Age related macular degeneration (AMD) is one of the commonest causes of certifiable visual impairment in the UK. There have been significant developments recently in our understanding of its underlying cause; in the options for therapeutic and surgical intervention; and in detection and diagnosis through emerging technology for retinal imaging; all of which have transformed the clinical management of a patient with AMD.

The AMD National Knowledge Week serves to provide a collection of the evidence and information on these recent developments in the clinical management of AMD. This is presented through a number of topic summaries reflecting aspects of the care pathway, including the patients’ perspective. Each summary is presented with on-line links wherever possible to cited references for current evidence and new knowledge (systematic reviews, primary research, and patient information). Printable versions of topic summaries are available, and of all the Specialist Libraries, the Eyes and Vision Specialist Library uniquely provides a low vision accessible web version of its NKWs.

Topics covered by the AMD NKW include:

Epidemiology - Dr Jennifer Evans

Genetics – Mr Andrew Webster

Emerging technology: Retinal imaging for diagnosis - Ms Samantha Mann

• Ocular coherence tomography (OCT)
• Auto-fluorescence (AF)

Developments in treatment:

• Therapeutic intervention : anti-VEGF therapy - Mr Yit Yang
• Surgical intervention : macular translocation – Mr Lyndon da Cruz

Low vision aids and AMD - Jane Macnaughton

Living with AMD - Macular Disease Society / EVSL Management Team

Freely available from 18^th June 2007: www.library.nhs.uk/eyes